Ottawa Regional Cancer Foundation

Recent papers from Ottawa Regional Cancer Foundation

1. The UVA-induced single-base mutational signature of CX-5461 in human cellsNucleic Acids Research · 2026
2. Exploring Key Unmet Supportive Care Needs of Adolescent and Young Adult Cancer Patients: A Qualitative Study to Inform Regional Program DevelopmentCurrent Oncology · 2026
3. An ounce of “superscreener”: A novel cancer screening program targeting unattached individualsCan J Public Health · 2026
4. Doxorubicin enhances adipogenesis in an FGF2-Dependent manner and Induces a Tumour-Promoting Secretory phenotypeJournal of bone oncology · 2026
5. Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trialsCancer · 2025
6. A field-test of Not Deciding Alone to support Inuit with health decision making: co-production of a mixed methods study guided by aajiiqatigiingniqInternational Journal of Circumpolar Health · 2025
7. A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancerBreast Cancer Research and Treatment · 2025
8. Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid TumorsCancer Research Communications · 2024
9. Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database StudyCancer Medicine · 2024
10. Co-creating a yoga program for women diagnosed with gynecologic cancer: a consensus studySupportive Care in Cancer · 2024
11. A Canadian real world prospective observational study assessing the impact of hormone therapy ± targeted therapy in the treatment of HR+ HER2- advanced breast cancer2024
12. Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisEuropean Urology · 2024
13. Access to cancer clinical trials for racialised older adults: an equity-focused rapid scoping review protocolBMJ Open · 2024
14. Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast CancerNew England Journal of Medicine · 2023
15. How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?NEJM Evidence · 2023
16. The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation StudyCancer Discovery · 2023
17. A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiomeTranslational Lung Cancer Research · 2023
18. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell CarcinomaEuropean Urology · 2023
19. NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).Journal of Clinical Oncology · 2023
20. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinomaCancer Reports · 2022